Stöllberger Claudia, Huber Johannes O, Finsterer Josef
Second Medical Department, Krankenanstalt Rudolfstiftung, Wien, Osterreich, Austria.
Int Clin Psychopharmacol. 2005 Sep;20(5):243-51. doi: 10.1097/01.yic.0000166405.49473.70.
Antipsychotic drugs (AD) are effective and frequently prescribed to more females than males. AD may cause serious cardiovascular side-effects, including prolonged QT interval, eventually leading to torsades de pointes (TdP) and sudden death. Epidemiologic data and case-control studies indicate an increased rate of sudden death in psychiatric patients taking AD. This review summarizes current knowledge about the QT prolonging effects of AD and gives practical suggestions. Amisulpride, clozapine, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perphenazine, pimozide, quetiapine, risperidone, sulpiride, thioridazine and ziprasidone cause a QT prolongation ranging from 4 ms for risperidone to 30 ms for thioridazine. Our knowledge about the QT-prolonging effects of many AD is still limited. Females are under-represented in most studies. Many studies were conducted or supported by pharmaceutical companies. To avoid prodysrhythmia caused by QT prolongation, other factors influencing QT interval have to be considered, such as other drugs affecting the same pathway, hypokalemia, hypomagnesemia, bradycardia, increased age, female sex, congestive heart failure and polymorphisms of genes coding ion channels or enzymes involved in drug metabolism. Because the response of a patient to AD is individual, an electrocardiogram recording the QT interval has to be performed at baseline, after AD introduction and after occurrence of any factor that might influence the QT interval.
抗精神病药物(AD)疗效显著,女性的处方量通常多于男性。AD可能会引发严重的心血管副作用,包括QT间期延长,最终导致尖端扭转型室速(TdP)和猝死。流行病学数据及病例对照研究表明,服用AD的精神科患者猝死率有所上升。本综述总结了当前关于AD延长QT间期作用的知识,并给出了实用建议。氨磺必利、氯氮平、氟哌噻吨、氟奋乃静、氟哌啶醇、美哌隆、奥氮平、奋乃静、匹莫齐特、喹硫平、利培酮、舒必利、硫利达嗪和齐拉西酮可使QT间期延长,幅度从利培酮的4毫秒到硫利达嗪的30毫秒不等。我们对许多AD延长QT间期作用的了解仍然有限。在大多数研究中,女性的代表性不足。许多研究是由制药公司开展或资助的。为避免QT间期延长导致的心律失常,必须考虑其他影响QT间期的因素,如影响同一途径的其他药物、低钾血症、低镁血症、心动过缓、年龄增长、女性性别、充血性心力衰竭以及编码参与药物代谢的离子通道或酶的基因多态性。由于患者对AD的反应因人而异,因此在基线时、开始使用AD后以及出现任何可能影响QT间期的因素后,都必须进行记录QT间期的心电图检查。